Hosier, Gregory W., and Naji J. Touma. “Response of Renal Cell Carcinoma to Ibrutinib, a Bruton Tyrosine Kinase Inhibitor, in a Patient Treated for Chronic Lymphocytic Leukemia”. Canadian Urological Association Journal 11, no. 5 (May 9, 2017): E237–9. Accessed May 26, 2022. https://cuaj.ca/index.php/journal/article/view/4316.